Donald Schreiber
Key Documents
Contact Information
-
Clinical Offices
Stanford Hospital & Clinics Emergency Medicine 300 Pasteur Drive, Alway Bldg M121 Emergency Dept, MC 5119 Stanford, CA 94305-2200 Tel Work (650) 725-9445 Fax (650) 723-0121Emergency Department 300 Pasteur Dr H1260 MC 5239 Stanford, CA 94305-5239 Tel Work (650) 725-4492 Fax (650) 736-7605
- Academic Offices
Personal Information Email Tel (650) 498-5220 Tel (650) 723-6576Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Emergency Medicine
Administrative Appointments
- Director Quality Improvement, Division of Emergency, Stanford University School of Medicine Medicine (2006 - present)
Professional Education
| Board Certification: | Emergency Medicine, American Board of Emergency Medicine (1983) |
| Internship: | Queen Elizabeth Hospital (1979) |
| Residency: | USC/LAC Medical Center CA (1982) |
| Medical Education: | Mcgill University, Canada (1978) |
| B. Eng: | McGill University, Electrical Engineering (1974) |
Postdoctoral Advisees
Scientific Focus
Current Research Interests
My research group focuses on the diagnosis and treatment of cardiovascular emergencies including acute myocardial infarction, acute cornary syndrome and congestive heart failure. We have evaluated a number of novel cardiac markers and point-of-care testing in clinical practice. Current projects also include the diagnosis and treatment of acute pulmonary embolism and deep venous thrombosis.
Publications
- A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the Disposition Impacted by Serial Point of Care Markers in Acute Coronary Syndromes (DISPO-ACS) trial. Ann Emerg Med. 2009; (3): 321-8
- Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol. 2007; (19): 1835-40
- Paroxysmal atrial fibrillation precipitated by amiodarone-induced thyrotoxicosis five months after cessation of therapy. J Emerg Med. 2006; (1): 61-4
- Statin-induced rhabdomyolysis. J Emerg Med. 2006; (2): 177-80
- Drug-related emergency department visits in an elderly veteran population. Ann Pharmacother. 2005; (12): 1990-5
Help